Lancet Oncol 10:321322
Because we are based in the United Kingdom, UK researchers benefit from fast, tracked domestic dispatch via Royal Mail Tracked 24, clear communication, and support from a team familiar with product composition, reconstitution, and storage
33 GENERAL APPROACH: IDENTIFY, CONFIRM, GIVE SUPPORTIVE CARE The most important clues for identifying and differentiating among deadly drug rashes are in the history, timing of exposure, and the bedside physical examination
Petrelintide (ZP8396) Petrelintide (ZP8396) is a novel SC-administered, long-acting amylin analog, developed by Zealand Pharma (Sborg, Denmark), a peptide drug discovery and development company, which is currently in early-stage clinical trials (phase 1 clinical trials: ClinicalTrials.gov Identifier NCT05511025, NCT05096598 and NCT05613387) [116]
TGF-1 is a cytokine with diverse roles in immune system modulation and tissue remodeling